Beckman Coulter Stock Soars as it Reportedly Seeks Buyer | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Beckman Coulter shot up more than 27 percent amid reports that it is looking for a buyer.

In early morning trading, shares of the Orange County, Calif.-based life science instrument, reagents, and diagnostics firm shot up to $72.77 after the Wall Street Journal reported it was shopping for a buyer in a sale that could fetch more than $5 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.